- Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology
- Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees
- Alexion to Present at the 40th Annual Cowen Health Care Conference
- Alexion to Present at the 9th Annual SVB Leerink Global Healthcare Conference
- Alexion Reports Fourth Quarter and Full Year 2019 Results
- Alexion Completes Acquisition of Achillion
- UPDATED TIME: Alexion Fourth Quarter and Full Year 2019 Results Conference Call at 7:30am ET on Thursday, January 30, 2020
- Alexion to Report Fourth Quarter and Full Year 2019 Results on Thursday, January 30, 2020
- Alexion Announces Planned Initiation of Pivotal Phase 3 Study of ULTOMIRIS® (ravulizumab) in ALS
- Alexion to Present at the 38th Annual J.P Morgan Healthcare Conference
Alexion Pharmaceuticals Inc (ALXN:NSQ) closed at 90.35, 24.33% above the 52 week low of 72.67 set on Mar 16, 2020.
72.67Mar 16 2020141.86Apr 10 2019
Markit short selling activity
|Market cap||20.07bn USD|
|EPS (TTM)||10.71 |
Data delayed at least 15 minutes, as of Apr 02 2020 21:00 BST.